Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

A phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndrome

Blood (2024) 144 (1): 35–45.

https://doi.org/10.1182/blood.2023022658

Published: 2024

Includes: Supplemental data

Journal Articles

Somatic mutations and clonal hematopoiesis in congenital neutropenia

Blood (2018) 131 (4): 408–416.

https://doi.org/10.1182/blood-2017-08-801985

Published: 2018

Includes: Supplemental data

Journal Articles

Granulocytic Precursors from Patients with ELA2-Mutant Severe Congenital Neutropenia Display a Transcriptional Profile Consistent with Activation of the Unfolded Protein Response.

Mark Murakami, Jun Xia, Catherine T. Jordan, Laurence A. Boxer, David Dale, Audrey A. Bolyard, Mary C. Dinauer, Daniel C. Link

Blood (2007) 110 (11): 662.

https://doi.org/10.1182/blood.V110.11.662.662

Published: 2007

Journal Articles

The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy

Philip S. Rosenberg, Blanche P. Alter, Audrey A. Bolyard, Mary Ann Bonilla, Laurence A. Boxer, Bonnie Cham, Carol Fier, Melvin Freedman, George Kannourakis, Sally Kinsey, Beate Schwinzer, Connie Zeidler, Karl Welte, David C. Dale, for the Severe Chronic Neutropenia International Registry

Blood (2006) 107 (12): 4628–4635.

https://doi.org/10.1182/blood-2005-11-4370

Published: 2006

Journal Articles

Genetic and Phenotypically Heterogeneity of Patients with Congenital Neutropenia.

Cornelia Zeidler, MD, Beate Schwinzer, PhD, Audrey A. Bolyard, RN, Gusal Pracht, Blanche P. Alter, MD, Mary A. Bonilla, MD, Bonnie Cham, MD, Carol Fier, RN, Melvin H. Freedman, MD, George Kannourakis, MD, Sally Kinsey, MD, Lawrence Boxer, MD, David C. Dale, MD, Karl Welte, MD

Blood (2005) 106 (11): 95.

https://doi.org/10.1182/blood.V106.11.95.95

Published: 2005

Journal Articles

The Incidence of Leukemia and Mortality from Sepsis in Patients with Severe Congenital Neutropenia Receiving Long-Term G-CSF Therapy.

Philip S. Rosenberg, PhD, Blanche P. Alter, MD, MPH, Audrey A. Bolyard, RN, Mary A. Bonilla, MD, Laurence A. Boxer, MD, Bonnie Cham, MD, Carol Fier, RN, Melvin Freedman, MD, George Kannourakis, MD, Sally Kinsey, MD, Beate Schwinzer, PhD, Connie Zeidler, MD, Karl Welte, MD, David C. Dale, MD

Blood (2005) 106 (11): 669.

https://doi.org/10.1182/blood.V106.11.669.669

Published: 2005

NARROW

A phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndrome

Somatic mutations and clonal hematopoiesis in congenital neutropenia

Granulocytic Precursors from Patients with ELA2-Mutant Severe Congenital Neutropenia Display a Transcriptional Profile Consistent with Activation of the Unfolded Protein Response.

The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy

Genetic and Phenotypically Heterogeneity of Patients with Congenital Neutropenia.

The Incidence of Leukemia and Mortality from Sepsis in Patients with Severe Congenital Neutropenia Receiving Long-Term G-CSF Therapy.

Email alerts

ASH Publications

American Society of Hematology

A phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndrome

Somatic mutations and clonal hematopoiesis in congenital neutropenia

Granulocytic Precursors from Patients with ELA2-Mutant Severe Congenital Neutropenia Display a Transcriptional Profile Consistent with Activation of the Unfolded Protein Response.

The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy

Genetic and Phenotypically Heterogeneity of Patients with Congenital Neutropenia.

The Incidence of Leukemia and Mortality from Sepsis in Patients with Severe Congenital Neutropenia Receiving Long-Term G-CSF Therapy.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only